Comparing Standard Platelet-Rich Plasma and Light-Enhanced Platelet-Rich Plasma for Treating Hair Loss in Androgenetic Alopecia: A Randomized Controlled Trial

Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-65
SponsorKimberly Meathrel

About this trial

The goal of this clinical trial is to compare 3 different types of PRP in androgenetic alopecia patients. The main questions it aims to answer:

Does Redlight enhanced, Blue light enhanced, or traditional PRP result in higher hair density and health? Does Redlight enhanced, Blue light enhanced, or traditional PRP result in other improved hair metrics.

Participants will consent to a PRP treatment but will be blinded to the type. They will then be asked to return for Tricholab analysis at set post-operative timepoints to record changes in hair metrics (Baseline, 1 month, 3 months, 6 months, 9 months, 12 months).

Eligibility criteria

Qualifiers

Age 18-65

Diagnosed Androgenetic Alopecia

Willing to comply with protocol and follow up

Disqualifiers

Active scalp infection or disease

Prior PRP within last 6 months

Use of hair growth medication topical or oral

Platelet dysfunction or anticoagulation

Trial design

Treatments tested in this trial

  • Platelet-Rich Plasma (PRP) Injections
  • Red-light photobiomodulation with cooling
  • Blue-light photobiomodulation

Treatment groups

30 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Kimberly Meathrel

Lead sponsor

BespokeSkin MD

Sponsor institution